Inmode Ltd
Research Inmode Ltd (INMD) on Bullrun: valuation model: 49.8% undervalued, market cap USD 933.91M, P/E 10.8. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerINMD
- ExchangeNASDAQ
- CountryIsrael
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signal49.8% undervalued
- Market capUSD 933.91M
- P/E10.8
- Financial periodFY2025
- RevenueUSD 370.50M
- Revenue growth-6.2%
- Net incomeUSD 93.83M
- Free cash flowUSD 84.29M
- Gross margin78.5%
Valuation Snapshot
Bullrun's latest valuation model marks Inmode Ltd as 49.8% undervalued; latest market cap is USD 933.91M; P/E is 10.8.
About Inmode Ltd
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Frequently asked questions
Is Inmode Ltd overvalued or undervalued?
Bullrun's valuation model currently marks Inmode Ltd as 49.8% undervalued.
What is Inmode Ltd's market cap?
Inmode Ltd's market capitalization is USD 933.91M.
What is Inmode Ltd's P/E ratio?
Inmode Ltd's price-to-earnings (P/E) ratio is 10.8.
What does Inmode Ltd do?
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.